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PreviewsCAT in the HAT: Catabolic inhibition by the histone
acetyltransferase GCN5
The nuclear hormone receptor coactivator PGC-1a is a key regulator of gluconeogenic genes during fasting. In this issue
of Cell Metabolism, Puigserver and colleagues (Lerin et al., 2006) report that the histone acetyltransferase GCN5 inhibits
gluconeogenesis by acetylating and sequestering PGC-1a in nuclear foci.‘‘.he alone knew something that
even the initiates didn’t know.
how easy it was to fast.’’
(Kafka, 1946)
First chronicled in Kafka’s short story
‘‘A Hunger Artist,’’ performers like Gio-
vanni Succi achieved a measure of noto-
riety throughout Europe at the turn of the
20th century by fasting for up to 45 days
at a time. For modern-day investigators
trying to understand the molecular mech-
anisms by which mammals maintain en-
ergy homeostasis, however, studies on
fasting have been anything but easy. In
the fasted state, plasma glucose levels
are maintained through an increase in
hepatic glucose output, primarily through
gluconeogenesis, in response to hor-
monal stimulation (Figure 1). But the
mechanism by which induction of the
gluconeogenic program during fasting is
coupled to nutrient availability has been
unclear. In this issue of Cell Metabolism,
Puigserver and colleagues show that the
histone acetyltransferase (HAT) GCN5 in-
hibits gluconeogenesis by acetylating the
nuclear hormone receptor PPARg coacti-
vator 1a (PGC-1a) (Lerin et al., 2006). The
results provide an unexpected link in this
regulatory cascade that may offer new
avenues for type II diabetes treatment.
Several key ingredients are critical for
glucose production: an adequate supply
of gluconeogenic precursors (lactate,
alanine, glycerol), a high ratio of
NAD+/NADH, and sufficient amounts
of relevant metabolic enzymes (e.g.,
PEPCK, pyruvate carboxylase, glucose-
6-phosphatase) for conversion of pyru-
vate to glucose. Elevations in circulating
pancreatic glucagon in response to hypo-
glycemia during fasting trigger expres-
sion of the gluconeogenic program via
the induction of PGC-1a (Herzig et al.,
2001; Yoon et al., 2001). PGC-1a in turn
stimulates transcription of gluconeogenic
genesby associating with a number of ac-
tivators, most notably HNF4 and FOXO1
(Lin et al., 2005). Indeed, PGC-1a expres-CELL METABOLISM 3, 387–392, JUNE 2006 ªsion is abnormally high in type II diabetes,
where it contributes to the attendant fast-
ing hyperglycemia and insulin resistance
associated with this disease.
Superimposed on this hormonal regu-
latory circuit, hepatic glucose output
is further modulated intracellularly by
AMPK, an energy-sensing Ser/Thr kinase
that blocks gluconeogenesis when cellu-
lar ATP levels are low (Shaw et al., 2005).
But how does the liver coordinate hor-
monal induction of the gluconeogenic
program with availability of metabolites
and cofactors?
Enter SIRT1, an NAD+-dependent his-
tone deacetylase (HDAC) that has been
shown to extend lifespan in yeast and
other organisms by repressing gene ex-
pression in response to caloric restriction
(Leibiger and Berggren, 2006). In a previ-
ous study, Puigserver and colleagues
found that fasting stimulates the accu-
mulation of SIRT1 protein in the liver
when cellular levels of the gluconeogenic
precursor pyruvate are high (Rodgers
et al., 2005). Notably, SIRT1 was found
to induce gluconeogenic gene expres-
sion by associating with and promoting
the deacetylation of PGC-1a when cellu-
lar NAD+/NADH ratios are elevated.
A key question from this study con-
cerned the identity of the enzyme that
acetylates PGC-1a. Under feeding con-
ditions, pancreatic insulin blocks glucose
output from the liver in part by phosphor-
ylation of FOXO1, a key regulator of glu-
coneogenic genes (Lin et al., 2005). The
Puigserver laboratory found a parallel
inhibitory pathway, triggered apparently
by nutrient signaling: They showed that
hepatic PGC-1a is heavily acetylated
during feeding, blocking its ability to me-
diate transcription via relevant activators
like HNF4 (Rodgers et al., 2005). They
performed mass spectrometry studies
on proteins associated with PGC-1a, in
the process uncovering components of
a HAT complex that contained GCN5.
First characterized as a positive regulator
for general control of amino acid biosyn-2006 ELSEVIER INC.thesis in S. cerevisiae, yeast GCN5 pro-
motes gene expression in response to
metabolic stressors such as glucose,
amino acid, or phosphate starvation by
acetylating promoter bound histones on
lysine and thereby increasing engage-
ment of the transcriptional machinery
(Kouzarides, 2000). In mammals, GCN5
and its paralog PCAF have also been
shown to catalyze the acetylation of cer-
tain transcription factors such as p53,
E2F1, TFIIEb, and TFIIF, and acetylation
of these proteins often leads to a change
in their stability or activity (Berger, 1999).
Puigserver and colleagues found that
GCN5 and PCAF were capable of acety-
lating PGC-1a in vitro, whereas other
HATs such as P300, SRC1, and Tip60
were not (Lerin et al., 2006)—a remark-
able finding because these enzymes are
often promiscuous with regard to sub-
strate recognition. Acetylation of PGC-
1a by GCN5 in liver disrupted the ex-
pression of the gluconeogenic program;
conversely, knockdown of GCN5 en-
hanced glucose output and gluconeo-
genic gene expression.
How does GCN5 inhibit PGC-1a? The
authors found that, following its acetyla-
tion, PGC-1a accumulated in nuclear
foci that contain the nuclear hormone co-
repressor RIP140. Although the mecha-
nism by which acetylation alters PGC-
1a localization was not addressed, the
ability of GCN5 to promote sequestration
of PGC-1a offers a potential mechanism
by which gluconeogenesis may be readily
fine tuned depending on nutrient status.
Some questions remain. Reports differ,
for example, as to whether NAD+/NADH
ratios during the feeding-to-fasting tran-
sition are different enough to modulate
hepatic SIRT1 activity significantly (Wil-
liamson et al., 1967). These results point
to the possibility that GCN5 activity is
itself also regulated and contributes to
the observed changes in PGC-1a acety-
lation status. In this regard, HATs such
as GCN5 have been found to modulate
gene expression in the context of other387
P R E V I E W SFigure 1. SIRT1 integrates nutrient and hormonal cues to modulate induction of the gluconeogenic program
During fasting, pancreatic glucagon stimulates expression of PGC-1a in the liver. Elevations in gluconeogenic
precursors like pyruvate promote accumulation of SIRT1 protein, which in turn triggers induction of gluconeo-
genic genes by catalyzing the NAD+-dependent deacetylation of PGC-1a.covalent modifications (e.g., phosphory-
lation or methylation), and the composite
of these modifications rather than any
one change alone is thought to provide
a signature code for transcriptional acti-
vation or repression. In S. cerevisiae, for
example, GCN5 and SNF1, the yeast ho-
molog of AMPK, coordinately regulate
gene expression by carrying out the se-
quential phosphorylation and acetylation
of histone H3 in response to glucose
depletion (Lo et al., 2001). In view of its
ability to block gluconeogenesis in mam-
mals, AMPK may similarly phosphorylate
and inhibit PGC-1a by enhancing subse-
quent acetylation via GCN5 when cellular
levels of ATP are low.
Future studies should reveal as well
the extent to which the observed antago-Hap1 and GABA: Thin
GABA stimulation of hypothalamic GABA
1 (Hap1), is highly expressed in the hyp
hypophagic. A recent paper (Sheng et al
Several major classes of molecules con-
trol synaptic signaling between brain cells.
One of these classes, neuropeptides, can
be considered to act at a system-wide
level, that is, causing diverse responses at
different sites in the brain that collectively
integrate toreachacommonendpoint.For
example, melanocortins such as a-mela-
nocyte-stimulating hormone (aMSH) act
in the hypothalamus, the brainstem,
and elsewhere to reduce energy intake
388nism between GCN5 and SIRT1 on PGC-
1a activity extends to other activators like
FOXO1 that also regulate gluconeogene-
sis. Should this yin-yang relationship be-
tween GCN5 and SIRT1 hold more gen-
erally, then compounds that enhance
GCN5 HAT activity might be expected
to provide therapeutic benefit for the
treatment of hyperglycemia and insulin
resistance in type 2 diabetic patients.
Whatever the results, the current study
provides much food for thought about
the regulatory mechanisms employed to
maintain energy balance during fasting.
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A receptors increases food intake and body
othalamus and increases activity at GAB
., 2006) further explores the role of Hap1 in
and increase energy expenditure (Cone,
2005); corticotropin-releasing hormone
(CRH) acts throughout the brain co-
ordinating endocrine and behavioral re-
sponses to real or perceived stressors
(Hillhouse and Grammatopoulos, 2006).
A second class of compounds, biogenic
amines, can be considered as setting a
background or tone that influences multi-
ple systems simultaneously. For example,
noradrenergic axons originating in theSelected reading
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brainstem radiate throughout the brain,
setting the level of arousal (Aston-Jones
and Cohen, 2005). At a different level, a
third class, amino acid transmitters such
as glutamate and g-aminobutyric acid
(GABA), do much of the synaptic work of
the brain, integrating inputs from multiple
sources to provide the appropriate level
of stimulation or inhibition to circuits con-
trolling responses. Indeed, glutamatergic
and GABAergic receptors collectively
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